Trade MOLN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Molecular Partners AG American Depositary Shares (MOLN) is trading at US$4.60, down 1.08% today as of Aug 28, 12:11 EDT. The company has a market capitalisation of US$165.05M. Over the past 52 weeks, MOLN has traded between US$3.53 and US$5.36. On Syfe you can trade MOLN with $0 commission and add it to your watchlist.
| Previous close | US$4.65 |
|---|---|
| Market cap | US$165.05M |
| 52-week range | US$3.53 – US$5.36 |
| Volume | 4.72K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Molecular Partners AG American Depositary Shares
Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. It also develops its products through its brand known as DARPins, which targets specific and potent monoclonal antibodies that offers potential to address existing limitations of antibody drugs. The company products include Abicipar, MP0250/MP0274, and Clinical Trials. The company was founded by Christian Zahnd, Patrick Amstutz, Patrik Forrer, Andreas Plückthun, and Michael Tobias Stumpp on November 22, 2004 and is headquartered in Schlieren, Switzerland.
Year: 2021
Molecular Partners Doses First Patients in Phase 2 Study of Biliary Tract Cancer Therapy
Jul 16, 7:34 AM · MT Newswires
Molecular Partners Makes Progress on Radiotherapy Cancer Candidates
Jul 6, 9:51 AM · MT Newswires
Molecular Partners Doses First Patients in Lung Cancer Trial
Jul 2, 7:46 AM · MT Newswires
Stay on top of MOLN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
